Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "digital-solutions"

47 News Found

Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
Healthcare | July 06, 2022

Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions

The AICVD tool can predict the risk of cardiovascular disease.


Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv
Digitisation | June 28, 2022

Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv

Strengthens investment in channels of the future to expand patient reach


Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
News | June 21, 2022

Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications

It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


PhableCare raises Rs 187 crore in Series B funding
Startup | April 12, 2022

PhableCare raises Rs 187 crore in Series B funding

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round


Novartis announces new organizational structure
Biotech | April 04, 2022

Novartis announces new organizational structure

New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity


Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
News | April 03, 2022

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024


Insilico Medicine and EQRx to jointly advance AI-driven drug discovery
Biotech | March 24, 2022

Insilico Medicine and EQRx to jointly advance AI-driven drug discovery

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices


Community approach crucial to stamp out diseases
Public Health | March 17, 2022

Community approach crucial to stamp out diseases

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges


RaphaCure partners with Madhavbaug for cardiac healthcare services
Clinical Trials | January 24, 2022

RaphaCure partners with Madhavbaug for cardiac healthcare services

Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals